Journal of Diabetes and Its Complications
Volume 18, Issue 1 , Pages 53-59 , 2 January 2004

AGE down-regulation of monocyte RAGE expression and its association with diabetic complications in type 1 diabetes

  • Junnosuke Miura

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +81-3-3353-8111x27114; fax: +81-3-3358-1941
    • Diabetes Center, Tokyo Women's Medical University School of Medicine, 8-1, Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan
    • ,
  • Yasuko Uchigata

      Affiliations

    • Diabetes Center, Tokyo Women's Medical University School of Medicine, 8-1, Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan
    • ,
  • Yasuhiko Yamamoto

      Affiliations

    • Department of Biochemistry and Molecular Vascular Biology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    • ,
  • Masayoshi Takeuchi

      Affiliations

    • Department of Biochemistry, Faculty of Pharmaceutical Science, Hokuriku University, Kanazawa, Japan
    • ,
  • Sigeru Sakurai

      Affiliations

    • Department of Biochemistry and Molecular Vascular Biology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    • ,
  • Takuo Watanabe

      Affiliations

    • Department of Biochemistry and Molecular Vascular Biology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    • Department of Stem Cell Biology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    • ,
  • Hideto Yonekura

      Affiliations

    • Department of Biochemistry and Molecular Vascular Biology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    • ,
  • Sho-ichi Yamagishi

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Fukuoka-ken, Japan
    • ,
  • Zenji Makita

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Fukuoka-ken, Japan
    • ,
  • Akiko Sato

      Affiliations

    • Diabetes Center, Tokyo Women's Medical University School of Medicine, 8-1, Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan
    • ,
  • Yasue Omori

      Affiliations

    • Diabetes Center, Eastern Japan Medical Institute, Kanagawa, Japan
    • ,
  • Hiroshi Yamamoto

      Affiliations

    • Department of Biochemistry and Molecular Vascular Biology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    • ,
  • Yasuhiko Iwamoto

      Affiliations

    • Diabetes Center, Tokyo Women's Medical University School of Medicine, 8-1, Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan

Received 7 August 2002 ,Revised 16 December 2002 ,Accepted 19 December 2002.

References 

  1. Ahmed MU, Thorpe SR, Baynes JW. Identification of Ne-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. Journal of Biological Chemistry. 1986;261:4889–4894
  2. Beisswenger PJ, Makita Z, Curphey TJ, Moore LL, Jean S, Brinck-Johnsen T, et al. Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes. Diabetes. 1995;44:824–829
  3. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. New England Journal of Medicine. 1988;318:1315–1321
  4. Furuta T, Saito T, Ootaka T, Soma J, Obara K, Abe K, et al. The role of macrophages in diabetic glomerulosclerosis. American Journal of Kidney Diseases. 1993;21:480–485
  5. Huang JS, Guh JY, Chen HC, Hung WC, Lai YH, Chuang LY. Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells. Journal of Cellular Biochemistry. 2001;81:102–113
  6. Ichikawa K, Yoshinari M, Iwase M, Wakisaka M, Doi Y, Iino K, et al. Advanced glycosylation end products induced tissue factor expression in human monocyte-like U937 cells and increased tissue factor expression in monocytes from diabetic patients. Atherosclerosis. 1998;136:281–287
  7. Iwashima Y, Eto M, Hata A, Kaku K, Horiuchi S, Ushikubi F, et al. Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages. Biochemical and Biophysical Research Communications. 2000;277:368–380
  8. Kislinger T, Fu C, Huber B, Qu W, Taguchi A, Yan SD, et al. Ne-(Carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. Journal of Biological Chemistry. 1999;274:31740–31749
  9. Lander HM, Tauras JM, Ogiste JS, Hori O, Moss RA, Schmidt AM. Activation of the receptor for advanced glycation end products triggers a p21ras-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. Journal of Biological Chemistry. 1997;272:17810–17814
  10. Makita Z, Radoff S, Rayfield EJ, Yang Z, Skolnik E, Delaney V, et al. Advanced glycosylation end products in patients with diabetic nephropathy. New England Journal of Medicine. 1991;325:836–842
  11. Mitsuhashi T, Nakayama H, Itoh T, Kuwajima S, Aoki S, Atsumi T, et al. Immunochemical detection of advanced glycation end products in renal cortex from STZ-induced diabetic rats. Diabetes. 1993;42:826–832
  12. Miura J, Yamagishi S, Uchigata Y, Takeuchi M, Yamamoto H, Makita Z, et al. Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with type 1 diabetes. Journal of Diabetes and Its Complications. 2003;17:16–21
  13. Nomura M, Yamagishi S, Harada S, Hayashi Y, Yamashima T, Yamashita J, et al. Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. Journal of Biological Chemistry. 1995;270:28316–28324
  14. Nomura T, Odagiri R, Demura R, Akashi H, Demura H. Evaluation of a new radioimmunoassay kit for urinary albumin. Journal of Medical and Pharmaceutical Science. 1989;22:213–220
  15. Schmidt AM, Yan SD, Brett J, Mora R, Nowygrod R, Stern D. Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. Journal of Clinical Investigation. 1993;91:2155–2168
  16. Schroder S, Palinski W, Schmid-Schonbein GW. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. American Journal of Pathology. 1991;139:81–100
  17. Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, Jishage K, et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature. 1997;386:292–296
  18. Takeuchi M, Bucala R, Suzuki T, Ohkubo T, Yamazaki M, Koike T, et al. Neurotoxicity of advanced glycation end-products for cultured cortical neurons. Journal of Neuropathology and Experimental Neurology. 2000;59:1094–1105
  19. Takeuchi M, Makita Z, Bucala R, Suzuki T, Koike T, Kameda Y. Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo. Molecular Medicine. 2000;6:114–125
  20. Tanaka N, Yonekura H, Yamagishi S, Fujimori H, Yamamoto Y, Yamamoto H. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-a through nuclear factor-κB, and by 17b-estradiol through Sp-1 in human vascular endothelial cells. Journal of Biological Chemistry. 2000;275:25781–25790
  21. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183–1197
  22. Vlassara H, Brownlee M, Cerami A. High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules. Proceedings of the National Academy of Sciences of the United States of America. 1985;82:5588–5592
  23. Vlassara H, Brownlee M, Cerami A. Macrophage receptor-mediated processing and regulation of advanced glycosylation endproduct (AGE)-modified proteins: role in diabetes and aging. Progress in Clinical and Biological Research. 1989;304:205–218
  24. Yamagishi S, Hsu CC, Taniguchi M, Harada S, Yamamoto Y, Ohsawa K, et al. Receptor-mediated toxicity to pericytes of advanced glycosylation end products a possible mechanism of pericytes loss in diabetic microangiopathy. Biochemical and Biophysical Research Communications. 1995;213:681–687
  25. Yamagishi S, Kawakami T, Fujimori H, Yonekura H, Tanaka N, Yamamoto Y, et al. Insulin stimulates the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. Microvascular Res. 1999;57:329–339
  26. Yamagishi S, Yonekura H, Yamamoto Y, Katsuno K, Sato F, Mita I, et al. Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. Journal of Biological Chemistry. 1997;272:8723–8730
  27. Yamamoto Y, Kato I, Doi T, Yonekura H, Ohashi S, Takeuchi M, et al. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. Journal of Clinical Investigation. 2001;108:251–258
  28. Yamamoto Y, Yamagishi S, Yonekura H, Doi T, Tsuji H, Kato I, et al. Role of the AGE–RAGE system in vascular injury in diabetes. Annals of the New York Academy of Science. 2000;902:163–172
  29. Yan SD, Schmidt AM, Anderson GM, Zhang J, Brett J, Zou YS, et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. Journal of Biological Chemistry. 1994;269:9889–9897
  30. Yeh CH, Sturgis L, Haidacher J, Zhang XN, Sherwood SJ, Bjercke RJ, et al. Requirement of p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-κB transcriptional activation and cytokine secretion. Diabetes. 2001;50:1495–1504
  31. Young BA, Johnson RJ, Alpers CE, Eng E, Gordon K, Floege J, et al. Cellular events in the evolution of experimental diabetic nephropathy. Kidney International. 1995;47:935–944

PII: S1056-8727(02)00281-7

doi: 10.1016/S1056-8727(02)00281-7

Journal of Diabetes and Its Complications
Volume 18, Issue 1 , Pages 53-59 , 2 January 2004

Article Tools

* Image Usage & Resolution